Dr. James Knorr is a Yuba City, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. James Knorr is G18730 for Ophthalmology in California. Dr. James Knorr is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. James Knorr speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
365 S Barrett Rd, Yuba City, California, 95991-5702
Phone:
530-673-4945
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1306199773
NPI Enumeration Date:
22 Oct, 2012
NPI Last Update On:
22 Oct, 2012
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. James Knorr are as mentioned below.
License Number
Specialization
State
Status
G18730
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
365 S Barrett Rd, Yuba City, California
Zip:
95991-5702
Phone Number:
530-673-4945
Fax Number:
--
Patients can reach Dr. James Knorr at 365 S Barrett Rd, Yuba City, California or can call to book an appointment on 530-673-4945. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.